Stay updated with breaking news from Mark Douglas Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year price target […]
LSV Asset Management lifted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,372,177 shares of the specialty pharmaceutical company’s stock after buying an additional 55,630 shares during the period. LSV […]
LSV Asset Management raised its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.4% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 2,372,177 shares of the specialty pharmaceutical company’s stock after purchasing an additional 55,630 shares during the period. LSV Asset Management’s holdings in Jazz Pharmaceuticals were worth $307,055,000 as of […]
Jackson Creek Investment Advisors LLC acquired a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,039 shares of the specialty pharmaceutical company’s stock, valued at approximately $652,000. Several other hedge funds […]
StockNews.com lowered shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) from a strong-buy rating to a buy rating in a report released on Monday. A number of other equities analysts have also recently commented on the stock. Raymond James initiated coverage on shares of Jazz Pharmaceuticals in a research report on Thursday, September 28th. They […]